← FDA Drug Approvals (Drugs@FDA)

SUCRALFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2026-01-05

Drug application

FDA Application #

ANDA212141

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUCRALFATE

Generic name

SUCRALFATE

Active ingredients

SUCRALFATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2026-01-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown